Abstract

The role of dietary components in immune function has acquired considerable attention in recent years. An important focus area is to unravel the role of bioactive dietary compounds in relation to enteric disease and their impact on gut mucosal immunity. Proanthocyanidins (PAC) are among the most common and most consumed dietary polyphenols, and are characterised by their variable molecular structures and diverse bioactivities. In particular, their anti-oxidative effects and ability to modulate gut microbiota have been widely described. However, there is limited evidence on the mechanism of action of PAC on the immune system, nor is it clearly established how PAC may influence susceptibility to enteric infections. Establishing the sites of action of PAC and their metabolites within the gut environment is fundamental to determine the applicability of PAC against enteric pathogens. Some mechanistic studies have shown that PAC have direct modulatory effects on immune cell signalling, isolated pathogens, and gut mucosal barrier integrity. Boosting the recruitment of immune cells and suppressing the amount of pro-inflammatory cytokines are modulating factors regulated by PAC, and can either be beneficial or detrimental in the course of re-establishing gut homeostasis. Herein, we review how PAC may alter distinct immune responses towards enteric bacterial, viral and parasitic infections, and how the modulation of gut microbiota may act as a mediating factor. Furthermore, we discuss how future studies could help unravel the role of PAC in preventing and/or alleviating intestinal inflammation and dysbiosis caused by enteric disease.

Highlights

  • The mammalian gut environment is an intricate ecosystem where multiple components such as epithelial cells, immune cells and the gut microbiota (GM) interact reciprocally with each other and regulate homeostasis [1]

  • We examine the immunomodulatory effects of dietary PAC, as well as emerging evidence that PAC may modulate immune function during enteric infection in both humans and animals

  • Dietary supplements that induce immunosuppressive effects may be beneficial for autoimmune disease, but may in turn be detrimental against infectious diseases by potentially giving rise to increased susceptibility of infection

Read more

Summary

Introduction

The mammalian gut environment is an intricate ecosystem where multiple components such as epithelial cells, immune cells and the gut microbiota (GM) interact reciprocally with each other and regulate homeostasis [1]. Whilst these positive effects of PAC are well-known in context of metabolic diseases, less is known about the role in PAC in regulating gut immunity to intestinal pathogen infection. Numerous studies in mouse and piglet models of intestinal inflammation have shown that dietary PAC can have beneficial effects, including promoting gut barrier integrity and mucosal morphology, and increasing goblet cell density and villi lengths [43, 44].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.